NEW YORK (GenomeWeb News) — BioServe today said it has acquired Genomics Collaborative from SeraCare Life Sciences for an undisclosed sum.
Genomics Collaborative offers access to a repository of 600,000 human DNA, tissue and serum samples that are “linked to detailed clinical and demographic data from 140,000 consented and anonymized patients collected on four continents, BioServe said.
BioServe said it will “fully” integrate Genomics Collaborative into its operations.
Bioserve said the acquisition “significantly expands” its pre-clinical service offerings and for drug discovery and development, allowing the company to offer a platform that takes “biomaterial to validated data.”
The combined platform will include DNA and RNA purification reagents, DNA sequencing, oligonucleotide synthesis, and genotyping services for studies of a variety of diseases, including cardiovascular disease, inflammatory disorders, several common cancers, and others.